None listed
Conditions
Brief summary
The purpose of this study is to assess the feasibility of an education and exercise program called Co-PreP in the context of prostate cancer. Who is it for? You may be eligible for this study if you are aged 18 or over are independently mobile and are receiving treatment for prostate cancer. Study details All participants in this study will attend a weekly outpatient group program prior to commencement of their treatment. The first session will include an hour of group exercise and an hour of education delivered by a nurse and physiotherapist. Subsequent sessions will include an hour of group exercise until commencement of treatment. Participants will complete a number of questionnaires before and after the program. It is hoped this research will demonstrate the feasibility of the Co-PreP program and contribute to improved physical function and decreased rates of anxiety and depression during and after commencement of cancer treatment.
Interventions
Co-PreP is a structured weekly outpatient group program, consisting of two components: 1) an hour of group exercise and 2) an hour of group education. For the initial session, participants are expected to attend both components of the program but will only be required to attend the one hour group exercise program for subsequent sessions. Participants will also be given the option to attend the education program for subsequent sessions if they feel that it will be of benefit. Participants who are
Co-PreP is a structured weekly outpatient group program, consisting of two components: 1) an hour of group exercise and 2) an hour of group education. For the initial session, participants are expected to attend both components of the program but will only be required to attend the one hour group exercise program for subsequent sessions. Participants will also be given the option to attend the education program for subsequent sessions if they feel that it will be of benefit. Participants who are flagged for radical prostatectomy or have a pre-existing continence issue will also be offered a half hour face to face pelvic floor and baseline continence assessment with an experienced continence physiotherapist This program will be completed in the outpatient setting of Sunshine hospital Education session The one hour education session will be delivered in a group setting by the prostate cancer nurse specialist and continence physiotherapist. Utilising powerpoint presentations and models, the health professionals will educate patients on topics, as listed below: - What is prostate cancer and biopsy results - Treatment expectations including catheter care and symptom management - Post treatment recovery and fatigue management - Continence and pelvic health - Physical and mental wellbeing - Diet including how to prevent constipation The presentations will take approximately 40 minutes, leaving 20 minutes for group discussions and questions and answer session. Further to these topics, an additional resource table will be set up to allow patients to collect brochures and gather further information on topics. Group exercise session The one hour group exercise training component will require participants to complete aerobic (walking and cycling) and strength (upper and lower limbs) training at a moderate to high intensity. Exercises will be progressed accordingly so as to ensure that participants are exercising at a level between 13 to 15 on the rate of perceived exertion (RPE) scale All sessions will be supervised by a registered physiotherapist who has expertise in delivering exercise programs for people with prostate cancer. Pelvic floor muscle training will also be incorporated as part of the group exercise session. In addition, participants will be advised to complete a minimum of two further exercise sessions in their home environment and will be provided with an exercise booklet and diary to encourage continuity of exercise outside of the program Participants will continue to attend these weekly sessions until commencement of treatment. Duration of the program will vary between 2 weeks and 4 months.
Sponsors
Western Health
Study design
Allocation
Non-randomised trial
Primary purpose
Treatment
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Prostate cancer patients receiving treatment at either Western Health or Peter MacCallum Sunshine Radiotherapy Centre. Treatment modalities may include radiotherapy, brachy therapy, radical prostatectomy, chemotherapy and hormone replacement therapies. Physically able to participate in an outpatient group exercise program as determined by their ability to ambulate independently with or without a gait aid. Cognitively able to comprehend information disseminated during the education session.
Exclusion criteria
Patients who are flagged for active surveillance for their prostate cancer. Patients who have pre-existing comorbidities hindering their ability to participate in an outpatient group exercise program: for example: unstable angina, stroke, severe musculoskeletal pain. Prostate cancer patients who are in the terminal phase of their illness, as deemed by the treating specialist(s). Prostate cancer patients who have pre-existing cognitive impairments or psychiatric history that will hinder their ability to participate. Patients who have a waiting time of less than 2 weeks before commencement of treatment.
Outcome results
None listed